By CHRIS MURPHEY and ALEXA VALIENT Nightline 08/07/15 https://abcnews.go.com/Health/company-claims-glasses-color-blind-people-perceive-colors/story?id=32948153A new type of glasses may help people who are color blind see the world in a whole new way.The Berkeley, California-based company EnChroma developed glasses with lenses that contain a special vertical filter that blocks out certain wavelengths, which helps the brain make distinctions between colors, […]
June is cataract awareness month. Cataract is clouding of the natural lens of the eye.More than 20 million Americans over the age of 40 have cataracts, and it is the most common cause of preventable blindness in the world.Cataracts do not hurt and they grow as time progresses. This growth is usually caused by our normal
Health Day NewsThe U.S. Food and Drug Administration on March, 2015 approved the use of Eylea, an injected drug, to treat diabetic retinopathy in patients with diabetic macular edema.According to the U.S. Centers for Disease Control and Prevention, diabetic retinopathy is a leading cause of blindness in American adults. A third of those over 40 with
Eylea has slight advantage over Avastin, Lucentis for people with macular edema, but cost is an issue. WebMD News from HealthDayBy Robert PreidtHealthDay ReporterWEDNESDAY, Feb. 18, 2015 (HealthDay News) — A vision-robbing condition called diabetic macular edema can strike people with diabetes.Now, a new study compared three leading drugs for the condition — Avastin, Eylea
Mark D. Fromer, MD Listed among New York Metro Area’s Top Doctors Dr. Fromer is driven by his desire to bring quality physicians to neighborhoods throughout New York NEW YORK, NY, December 10, 2014, Mark D. Fromer, MD with Fromer Eye Centers has been recognized for showing dedication, leadership and excellence in eye care.
Combined iStent Trabecular Micro-bypass Stent Implantation and Phacoemulsification for Coexistent Open-angle Glaucoma and Cataract What is iStent? The iStent Trabecular Micro-Bypass stent is a new surgical therapy for glaucoma that is designed to improve aqueous outflow to safely lower IOP and may reduce medication burden; but this will be at the discretion of your physician.